National Comprehensive Cancer Network



About NCCN

Hodgkin Lymphoma Panel - Disclosures as of 11/6/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Ranjana H. Advani, MD

None

Eisai Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Seattle Genetics

None

None

None

Weiyun Z. Ai, MD

None

None

None

None

None

Richard F. Ambinder, MD, PhD

None

None

None

None

None

Patricia Aoun, MD, MPH

None

None

None

None

None

Celeste M. Bello, MD, MSPH

Seattle Genetics

Seattle Genetics;
Spectrum Pharmaceuticals

None

None

None

Cecil M. Benitez, PhD

None

None

None

None

None

Philip J. Bierman, MD

None

None

None

None

None

Kristie A. Blum, MD

None

None

None

None

None

Jennifer Burns

None

None

None

None

None

Robert Chen, MD

Seattle Genetics

Millennium Pharmaceuticals, Inc.;
Seattle Genetics;
Seattle Genetics

None

None

None

Bouthaina Dabaja, MD

None

None

None

None

None

Richard I. Fisher, MD

None

Boehringer Ingelheim GmbH;
Bio Linx;
Hoffman LaRoche;
Micromet;
Pfizer Inc.

None

None

None

Andres Forero, MD

Abbott Laboratories;
Biogen Idec;
Celgene Corporation;
Daiichi- Sankyo Co.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Leo I. Gordon, MD

None

CureTech Ltd.

None

CureTech Ltd.

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Francisco Hernandez-Ilizaliturri, MD

None

Amgen Inc.;
Millennium Pharmaceuticals, Inc.;
Seattle Genetics

None

None

None

Ephraim P. Hochberg, MD

None

Biogen Idec;
Genentech, Inc.;
Proventys/NCCN;
Seatle Genetics;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

Richard T. Hoppe, MD

None

Clarient;
Takeda Pharmaceuticals North America, Inc.

None

None

None

Jiayi Huang, MD

None

None

None

None

None

David G. Maloney, MD, PhD

None

Genentech, Inc.;
F. Hoffmann-La Roche Ltd.

None

None

None

Peter Mauch, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Monika Metzger, MD

None

None

None

None

None

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

David Morgan, MD

None

None

None

None

None

Craig H. Moskowitz, MD

None

GlaxoSmithKline;
Seattle Genetics;
Roche Laboratories, Inc.

None

None

None

Carolyn Mulroney, MD

None

None

None

None

None

Matthew Poppe, MD

None

None

None

None

None

Rachel Rabinovitch, MD

None

None

None

None

None

Hema Sundar, PhD

None

None

None

None

None

Sarika Trikha, PharmD

None

None

None

None

None

Jane N. Winter, MD

None

Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

None

None

Joachim Yahalom, MD

None

None

None

None

None